SCHEMBL21164826

SCHEMBL21164826

C/C(=N/NC(C)C)c1ccc([S+]([O-])c2ccc(/C(C)=N\NC(C)C)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ MAPT P10636 3/20 0.33
▸ GAA P10253 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ METTL3 Q86U44 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ HTT P42858 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18001528 0.87 ALDH1A1 (0.31) ALDH1A1L3MBTL1
SCHEMBL18015096 0.80 GAA (0.36) MAPTGAAKMT2AMEN1NPC1
SCHEMBL23333903 0.78 RAB9A (0.43) ALDH1A1L3MBTL1MAPTGAAKMT2A
SCHEMBL23392919 0.78 RAB9A (0.43) ALDH1A1L3MBTL1MAPTGAAKMT2A
SCHEMBL23392921 0.78 RAB9A (0.43) ALDH1A1L3MBTL1MAPTGAAKMT2A
SCHEMBL17276528 0.76 MAPT (0.55) ALDH1A1L3MBTL1MAPTGAAKMT2A
SCHEMBL25581428 0.75 RXFP1 (0.42) ALDH1A1L3MBTL1MAPTGAAKMT2A
SCHEMBL27045464 0.74 ALDH1A1 (0.63) ALDH1A1L3MBTL1MAPTGAAKMT2A
SCHEMBL16595860 0.72 MAPT (0.43) ALDH1A1L3MBTL1MAPTKMT2AMEN1
SCHEMBL25581431 0.72 KMT2A (0.49) ALDH1A1MAPTGAAKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10351662-B2 Degradable hydrazone curing agents and applications thereof ADESSO ADVANCED MATERIALS WUHU CO., LTD. (CN) 2019-07-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10351662-B2 Degradable hydrazone curing agents and applications thereof EGLN2, EGLN3, P4HA1 ALDH1A1 319/4885L3MBTL1 4743/4885MAPT 3776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback